Lazard to acquire Campbell Lutyens for up to $660M, expanding private capital advisory

Filed May 1, 2026 · Period ending April 30, 2026 · ~1 min read

Key Changes

• high

  Lazard agreed to acquire 100% of Campbell Lutyens, a global private capital advisor, for up to $660 million: $460M at closing (mostly stock at $46.50/share), $115M deferred two years, and up to $85M contingent on revenue growth through 2030.

  Item 1.01: Purchase Agreement verify on EDGAR →
• high

  Stock issuance capped at 19.99% of outstanding shares per NYSE rules, limiting dilution. Any excess consideration will be paid in cash or loan notes instead of additional stock.

  Item 1.01: Stock issuance cap verify on EDGAR →
• medium

  Lazard must pay $50M termination fee if deal fails due to U.K. Competition and Markets Authority approval not being obtained. Transaction must close by March 31, 2027.

  Item 1.01: Termination provisions verify on EDGAR →